Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Yang
L. Yang
Bristol-Myers Squibb
Immunology
Urology
Belatacept
Medicine
Diabetes mellitus
3
Papers
92
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
De novo donor‐specific antibodies in belatacept‐treated vs cyclosporine‐treated kidney‐transplant recipients: Post hoc analyses of the randomized phase III BENEFIT and BENEFIT‐EXT studies
2018
American Journal of Transplantation
Robert A. Bray
Howard M. Gebel
Robert Townsend
M. E. Roberts
Martin S. Polinsky
L. Yang
H.-U. Meier-Kriesche
Christian P. Larsen
Show All
Source
Cite
Save
Citations (52)
Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT
2018
American Journal of Transplantation
Robert A. Bray
Howard M. Gebel
Robert Townsend
M. E. Roberts
Martin S. Polinsky
L. Yang
H.-U. Meier-Kriesche
Christian P. Larsen
Show All
Source
Cite
Save
Citations (21)
Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly
2017
American Journal of Transplantation
Flavio Vincenti
G. Blancho
Antoine Durrbach
G. Grannas
J. Grinyo
H.-U. Meier-Kriesche
Martin S. Polinsky
L. Yang
Christian P. Larsen
Show All
Source
Cite
Save
Citations (19)
1